Clearance Summary
HDL-Cholesterol Gen.4 received FDA 510(k) clearance under submission number K162593, sponsored by Roche Diagnostics Operations (Rdo). The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2016-10-19.
- Submission: K162593
- Applicant / Sponsor: Roche Diagnostics Operations (Rdo)
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1475
- Decision date: 2016-10-19
Classification & Regulation
This clearance is catalogued under FDA product code LBS and 21 CFR 862.1475, within the Clinical Chemistry review panel as a Class I device.